Offer - Urjas Oil for just ₹ 1 X
Warf 5 Tablet (30) is a prescription drug, available for use as Tablet. Pulmonary Embolism, Deep Vein Thrombosis, Blood Clotting Disorders are some of its major therapeutic uses. Secondary and off-label uses of Warf 5 Tablet (30) have also been mentioned below.
The optimal dosage of Warf 5 Tablet (30) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Warf 5 Tablet (30) as well, which are listed below. These side effects of Warf 5 Tablet (30) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Warf 5 Tablet (30)'s effect during pregnancy is Moderate and Moderate while nursing. In addition, Warf 5 Tablet (30)'s effects on the liver, heart and kidney are discussed below in the Warf 5 Tablet (30) related warnings section.
Warf 5 Tablet (30) is contraindicated in people with pre-existing medical conditions like Bleeding, Diabetes, High Blood Pressure as it can result in adverse effects. Other conditions have been mentioned below in the Warf 5 Tablet (30) contraindications section.
Additionally, Warf 5 Tablet (30) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Warf 5 Tablet (30) is considered safe while driving, and is addictive.
Warf 5 Tablet (30) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Warf 5 Tablet (30) safe for pregnant women?
Pregnant women may experience moderate side effects from Warf. It is best to stop taking Warf immediately and inform your doctor if you notice any discomfort.
Is the use of Warf 5 Tablet (30) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Warf. Immediately discontinue Warf if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Warf 5 Tablet (30) on the Kidneys?
Warf has very mild side effects on the kidneys.
What is the effect of Warf 5 Tablet (30) on the Liver?
Very few cases of side effects of Warf on the liver have been reported.
What is the effect of Warf 5 Tablet (30) on the Heart?
Warf may have severe effects on your heart, so do not take it without first consulting your doctor.
Warf 5 Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Warf 5 Tablet (30) unless your doctor advises you to do so -
Is this Warf 5 Tablet (30) habit forming or addictive?
Warf 5 Tablet (30) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Warf 5 Tablet (30) as it does not make you drowsy.
Is it safe?
Warf 5 Tablet (30) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Warf 5 Tablet (30) for mental disorders.
Interaction between Food and Warf 5 Tablet (30)
Information is not available on the interaction of any foods with Warf 5 Tablet (30), due to a lack of research on this.
Interaction between Alcohol and Warf 5 Tablet (30)
Due to lack of research, there is no information about the side effects of taking Warf 5 Tablet (30) with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1283-1284
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 620-622
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coumadin (warfarin sodium)